Tonix Pharmaceuticals Holding Corp. financial statements, including revenue, expenses, profit, and loss
The total revenue of TNXP for the last quarter is 3.78 M USD, and it's 5.26% lower compared to the previous quarter. The net income of Q4 23 is -27.32 M USD.